- Sideli, Lucia
- Aas, Monica
- Alameda, Luis
- Trotta, Giulia
- La Barbera, Daniele
- La Cascia, Caterina
- Ferraro, Laura
- Velthorst, Eva
- Tripoli, Giada
- Schimmenti, Adriano
- Fontana, Andrea
- Quattrone, Diego
- Gayer-Anderson, Charlotte
- Rodriguez, Victoria
- Spinazzola, Edoardo
- Stilo, Simona
- Seminerio, Fabio
- Sartorio, Crocettarachele
- Marrazzo, Giovanna
- Lasalvia, Antonio
- Tosato, Sarah
- Tarricone, Ilaria
- D'Andrea, Giuseppe
- Amoretti, Silvia
- Andreu-Bernabeu, Álvaro
- Baudin, Grégoire
- Beards, Stephanie
- Bonetto, Chiara
- Bonora, Elena
- Cabrera, Bibiana
- Carracedo, Angel
- Charpeaud, Thomas
- Costas, Javier
- Cristofalo, Doriana
- Durán-Cutilla, Manuel
- Ferchiou, Aziz
- Fraguas, David
- Franke, Nathalie
- Frijda, Flora
- Llorente, Cloe
- Garcia-Portilla, Paz
- González Peñas, Javier
- Hubbard, Kathryn
- Jamain, Stéphane
- Jiménez-López, Estela
- Leboyer, Marion
- López Montoya, Gonzalo
- Lorente-Rovira, Esther
- Díaz-Caneja, Covadonga M.
- Marcelino Loureiro, Camila
- Mayoral, Maria
- Merchan, Jessica
- Moreno, Dolores M.
- Messchaart, Elles
- Moltó, Ma Dolores
- Mezquida, Gisela
- Moreno, Carmen
- Muratori, Roberto
- Juan, Nacher
- Parellada, Mara
- Rapado-Castro, Marta
- Ruggeri, Mirella
- Richard, Jean Romain
- Solano, Rodríguez
- Juan, José
- Sáiz, Pilar A.
- Sánchez-Gutierrez, Teresa
- Sánchez, Emilio
- Franck, Schürhoff
- Seri, Marco
- Shuhama, Rosana
- Termorshuizen, Fabian
- Tronche, Anne Marie
- van Dam, Daniella
- van der Ven, Elsje
- Arango, Celso
- Arrojo, Manuel
- Bernardo, Miguel
- Bobes, Julio
- Sanjuán, Julio
- Santos, Jose Luis
- Menezes, Paulo Rossi
- Del-Ben, Cristina Marta
- Jongsma, Hannah E.
- Jones, Peter B.
- Kirkbride, James B.
- Llorca, Pierre Michel
- Tortelli, Andrea
- Pignon, Baptiste
- de Haan, Lieuwe
- Selten, Jean Paul
- Van Os, Jim
- Rutten, Bart P.
- Di Forti, Marta
- Murray, Robin M.
- Morgan, Craig
- Fisher, Helen L.
- EU-GEI WP2 Group
EU-GEI WP2 Group
The European Network of National Schizophrenia Networks Studying Gene-Environment Interactions (EU-GEI) WP2 Group members includes: Silvia Amoretti, PhD, Barcelona Clinic Schizophrenia Unit, Hospital Clinic, Departament de Medicina, Institut de Neurociències (UBNeuro), Universitat de Barcelona (UB), Institut d'Investigacions Biomèdiques, August Pi I Sunyer (IDIBAPS), Barcelona, Spain; Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain; Álvaro Andreu-Bernabeu, Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain; Grégoire Baudin, MSc, AP-HP, Groupe Hospitalier ‘Mondor’, Pôle de Psychiatrie, Créteil, France, Institut National de la Santé et de la Recherche Médicale, U955, Créteil, France; Stephanie Beards, PhD, Department of Health Service and Population Research, Institute of Psychiatry, King's College London, London, England; Chiara Bonetto, PhD, Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona, Italy; Elena Bonora, PhD, Department of Medical and Surgical Science, Genetic Unit, Alma Mater Studiorium Università di Bologna, Bologna, Italy; Bibiana Cabrera, MSc, PhD, Barcelona Clinic Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, Barcelona, Spain, CIBERSAM, Spain; Angel Carracedo, MD, PhD, Fundación Pública Galega de Medicina Xenómica, Hospital Clínico Universitario, CIBERER, Santiago de Compostela, Spain; Thomas Charpeaud, MD, Fondation Fondamental, Créteil, France, CMP B CHU, Clermont Ferrand, France and Université Clermont Auvergne, Clermont-Ferrand, France; Javier Costas, PhD, Fundación Pública Galega de Medicina Xenómica, Hospital Clínico Universitario, Santiago de Compostela, Spain; Doriana Cristofalo, MA, Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona, Italy; Manuel Durán-Cutilla, MD, Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, Institute of Psychiatry and Mental Health, IiSGM, School of Medicine, Universidad Complutense, Madrid, Spain; Aziz Ferchiou, MD, AP-HP, Groupe Hospitalier ‘Mondor’, Pôle de Psychiatrie, Créteil, France, Institut National de la Santé et de la Recherche Médicale, U955, Créteil, France; David Fraguas, MD, PhD, Biomedical Research Networking Center for Mental Health Network (CIBERSAM), Barcelona, Spain; Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, Institute of Psychiatry and Mental Health, IiSGM, School of Medicine, Universidad Complutense, Madrid, Spain; Nathalie Franke, MSc, Department of Psychiatry, Early Psychosis Section, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands; Flora Frijda, MSc, Etablissement Public de Santé Maison Blanche, Paris, France; Cloe Llorente, MD, Department of Psychiatry, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, Investigación Sanitaria del Hospital Gregorio Marañón (CIBERSAM), Madrid, Spain; Paz Garcia-Portilla, MD, PhD, Department of Medicine, Psychiatry Area, School of Medicine, Universidad de Oviedo, ISPA, INEUROPA, CIBERSAM, Oviedo, Spain; Javier González Peñas, Hospital Gregorio Marañón (CIBERSAM), IiSGM, School of Medicine, Madrid, Spain; Kathryn Hubbard, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London; Stéphane Jamain, PhD, Institut National de la Santé et de la Recherche Médicale, U955, Créteil, France, Faculté de Médecine, Université Paris-Est, Créteil, France and Fondation Fondamental, Créteil, France; Estela Jiménez-López, MSc, Department of Psychiatry, Servicio de Psiquiatría Hospital ‘Virgen de la Luz,’ Cuenca, Spain; Marion Leboyer, MD, PhD, AP-HP, Groupe Hospitalier ‘Mondor,’ Pôle de Psychiatrie, Créteil, France, Institut National de la Santé et de la Recherche Médicale, U955, Créteil, France, Faculté de Médecine, Université Paris-Est, Créteil, France and Fondation Fondamental, Créteil, France; Gonzalo López Montoya, PhD, Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM (CIBERSAM), Madrid, Spain; Esther Lorente-Rovira, PhD, Department of Psychiatry, School of Medicine, Universidad de Valencia, CIBERSAM, Valencia, Spain; Covadonga M. Díaz-Caneja, Child and Adolescent Psychiatry Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain; Camila Marcelino Loureiro, MD, Departamento de Neurociências e Ciencias do Comportamento, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, São Paulo, Brasil and Núcleo de Pesquina em Saúde Mental Populacional, Universidade de São Paulo, São Paulo, Brasil; Maria Mayoral, Institute of Psychiatry and Mental health, Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IIiSGM, CIBERSAM, Madrid, Spain; Jessica Merchan, Institute of Psychiatry and Mental health, Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IIiSGM, CIBERSAM, Madrid, Spain; Dolores M. Moreno, Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM (CIBERSAM), Madrid, Spain; Elles Messchaart, MSc, Rivierduinen Centre for Mental Health, Leiden, the Netherlands; Ma Dolores Moltó, Department of Genetics, University of Valencia, Campus of Burjassot, Biomedical Research Institute INCLIVA, Valencia, Spain, Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Madrid, Spain; Gisela Mezquida, PhD, Barcelona Clinic Schizophrenia Unit, Hospital Clinic, Departament de Medicina, Institut de Neurociències (UBNeuro), Universitat de Barcelona (UB), Institut d'Investigacions Biomèdiques, August Pi I Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM), Instituto de Salud Carlos III, Madrid, Spain; Carmen Moreno, MD, Department of Psychiatry, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM (CIBERSAM), Madrid, Spain; Roberto Muratori, MD, Department of Mental Health and Pathological Addiction, Local Health Authority, Bologna, Italy; Nacher Juan, Neurobiology Unit, Department of Cell Biology, Interdisciplinary Research Structure for Biotechnology and Biomedicine (BIOTECMED), Universitat de València, Valencia, Spain, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM): Spanish National Network for Research in Mental Health, Madrid, Spain, Fundación Investigación Hospital Clínico de Valencia, INCLIVA, Valencia, Spain; Mara Parellada, MD, PhD, Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM (CIBERSAM), Madrid, Spain; Marta Rapado-Castro, PhD, Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, Institute of Psychiatry and Mental Health, IiSGM, School of Medicine, Universidad Complutense, Madrid, Spain; Mirella Ruggeri, MD, PhD, Section of Psychiatry, Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona, Italy; Jean-Romain Richard, MSc, Institut National de la Santé et de la Recherche Médicale, U955, Créteil, France and Fondation Fondamental, Créteil, France; Rodríguez Solano, José Juan, MD, Puente de Vallecas Mental Health Department, Hospital Universitario Infanta Leonor/Hospital Virgen de la Torre, Centro de Salud Mental Puente de Vallecas, Madrid, Spain; Pilar A. Sáiz, Department of Psychiatry, School of Medicine, University of Oviedo, CIBERSAM. Instituto de Neurociencias del Principado de Asturias, INEUROPA, Oviedo, Spain; Servicio de Salud del Principado de Asturias (SESPA), Oviedo, Spain; Teresa Sánchez-Gutierrez, Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM, CIBERSAM, C/Doctor Esquerdo 46, 28007 Madrid, Spain. Faculty of Health Science. Universidad Internacional de La Rioja (UNIR), Madrid, Spain; Emilio Sánchez, MD, Department of Psychiatry, Hospital General Universitario Gregorio Marañón, School of Medicine, Universidad Complutense, IiSGM (CIBERSAM), Madrid, Spain; Schürhoff, Franck, MD, PhD, AP-HP, Groupe Hospitalier ‘Mondor,’ Pôle de Psychiatrie, Créteil, France, Institut National de la Santé et de la Recherche Médicale, U955, Créteil, France, Faculté de Médecine, Université Paris-Est, Créteil, France and Fondation Fondamental, Créteil, France; Marco Seri, MD, Department of Medical and Surgical Science, Genetic Unit, Alma Mater Studiorium Università di Bologna, Bologna, Italy; Rosana Shuhama, PhD, Departamento de Neurociências e Ciencias do Comportamento, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, São Paulo, Brasil and Núcleo de Pesquina emSaúde Mental Populacional, Universidade de São Paulo, São Paulo, Brasil; Fabian Termorshuizen, PhD, Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, South Limburg Mental Health Research and Teaching Network, Maastricht University Medical Centre, Maastricht, the Netherlands and Rivierduinen Centre for Mental Health, Leiden, the Netherlands; Anne-Marie Tronche, MD, Fondation Fondamental, Créteil, France, CMP B CHU, Clermont Ferrand, France and Université Clermont Auvergne, ClermontFerrand, France; Daniella van Dam, PhD, Department of Psychiatry, Early Psychosis Section, Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands; Elsje van der Ven, PhD, Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience,n and Teaching Network, Maastricht University Medical Centre, Maastricht, the Netherlands and Rivierduinen Centre for Mental Health, Leiden, the Netherlands., [Introduction]
Evidence suggests that childhood maltreatment affects cognitive performance in both patients with psychosis and community controls. However, the interplay between childhood maltreatment, post-traumatic stress symptoms (PTSS), and intelligence has not been investigated. This study investigated the relationship between childhood maltreatment, subclinical PTSS, and intelligence among patients with first-episode psychosis (FEP) and community controls., [Methods]
Patients with FEP (N = 602) and controls (N = 853) from the EU-GEI study were assessed for childhood maltreatment, PTSS, and intelligence quotient (IQ)., [Results]
PTSS were associated with lower IQ among community controls but not among patients with FEP. In the FEP group, an interaction (p = 0.044) between PTSS and childhood maltreatment on IQ was found, such that the association between PTSS and lower IQ was only present among those exposed to childhood maltreatment. No interaction was evident in controls (p = 0.826)., [Conclusions]
The findings suggest the relevance of cognitive rehabilitation for FEP patients with childhood maltreatment and PTSS., The EU-GEI Study is funded by the European Community's Seventh Framework Programme [HEALTH-F2-2010-241909] (Project EU-GEI) and the São Paulo Research Foundation [2012/0417-0]. Monica Aas is supported by a Medical Research Council (MRC) fellowship [MR/W027720/1]. Luis Alameda was supported by fellowships from Fondation Adrian et Simone Frutiger and Carigest SA. Celso Arango has received support from the Spanish Ministry of Science, Innovation and Universities, Instituto de Salud Carlos III (ISCIII), co-financed by the European Union, European Regional Development Funds from the European Commission, ‘A way of making Europe’, financed by the European Union NextGenerationEU [PMP21/00051, PI19/01024, PI22/01824], CIBERSAM, Government of the Community of Madrid [B2017/BMD-3740, AGES-CM-2], European Union Structural Funds, European Union Seventh Framework Programme, European Union H2020 Programme under the Innovative Medicines Initiative 2 Joint Undertaking: Project PRISM-2 [101034377], Project AIMS-2-TRIALS [777394], Horizon Europe, the National Institute of Mental Health [1U01MH124639-01 ProNET, 5P50MH115846-03 FEP-CAUSAL], Fundación Familia Alonso and Fundación Alicia Koplowitz. Helen L. Fisher, Charlotte Gayer-Anderson and Craig Morgan are supported by the Economic and Social Research Council (ESRC) Centre for Society and Mental Health at King's College London [ES/S012567/1]. Diego Quattrone is supported by the MRC Clinical Academic Research Partnership [MR/W030608/1]. Edoardo Spinazzola was supported by Lord Leverhulme's Charitable Trust and the Velvet Foundation and by the MRC [MR/T007818/1]. Bart P. Rutten is funded by a VIDI award from the Dutch Research Council [91.718.336]. The views expressed are those of the authors and not necessarily those of the ESRC or King's College London.
The members of EU-GEI WP2 Group are listed in Appendix A.
Craig Morgan and Helen L. Fisher contributed equally to this work and they are joint senior authors., Peer reviewed